GEDTX Performance — GMO Emerging Markets Select Equity Fund, Class II
Data updated: 2023-10-27
GEDTX returned +3.40% over one year to Aug 2023. The annualised 3-year return is −4.65%. The fund trailed its Money Market category average: $100 invested three years ago grew to $87, against $106 for the category, and to $103 over one year, against $104. Volatility over the past three years was 16.67% a year. In the 12 months to Aug 2023 the fund lost a net $91.8M, and assets reached $67.20M.
GEDTX Growth of $100
What $100 invested in GMO Emerging Markets Select Equity Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Money Market category average over the same months.
| Period | GEDTX | Category average |
|---|---|---|
| 1 year (Sep 2022 – Aug 2023) | $103 | $104 |
| 3 years (Sep 2020 – Aug 2023) | $87 | $106 |
| Since data start (Sep 2019 – Aug 2023) | $100 | $110 |
GEDTX Trailing Returns
Total returns to Aug 2023, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | +3.40% |
| 3 years (annualised) | −4.65% |
GEDTX Annual Returns
Calendar-year total returns of GMO Emerging Markets Select Equity Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2023 (Jan–Aug) | +7.38% |
| 2022 | −24.60% |
| 2021 | −5.21% |
| 2020 | +18.21% |
| 2019 (Sep–Dec) | +10.57% |
GEDTX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | +9.5% | −5.0% | +3.5% | −2.1% | −1.0% | +3.7% | +4.1% | −4.7% | — | — | — | — |
| 2022 | −0.7% | −5.9% | −3.4% | −5.2% | −0.4% | −6.2% | −0.9% | −1.1% | −9.3% | −4.5% | +14.6% | −3.0% |
| 2021 | +2.7% | +0.3% | −2.5% | +1.3% | +1.6% | +0.9% | −5.6% | +0.7% | −4.0% | +1.9% | −4.7% | +2.6% |
| 2020 | −4.5% | −3.2% | −13.8% | +6.7% | +2.2% | +6.7% | +9.6% | +3.0% | −1.1% | +0.9% | +5.9% | +6.8% |
| 2019 | — | — | — | — | — | — | — | — | +1.5% | +2.8% | −0.7% | +6.8% |
GEDTX Risk
Risk measures from monthly returns over Sep 2020 – Aug 2023.
- 3-year volatility (annualised): 16.67%
- 3-year Sharpe ratio: -0.55 (vs 4.5% risk-free rate)
- Best month: +14.62% (Nov 2022)
- Worst month: −9.33% (Sep 2022)
GEDTX Fund Flows
Monthly money in and out of GMO Emerging Markets Select Equity Fund, from SEC Form N-PORT.
- 12-month net flow: −$91.8M
- 12-month gross sales (incl. reinvestments): $21.4M
- Sales ÷ redemptions: 0.19×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Aug 2023 | $50K | $2.5M | −$2.5M |
| Jul 2023 | $255K | $61K | $194K |
| Jun 2023 | $110K | $0 | $110K |
| May 2023 | $18.1M | $0 | $18.1M |
| Apr 2023 | $14K | $52.7M | −$52.7M |
| Mar 2023 | $290K | $26.6M | −$26.3M |
| Feb 2023 | $100K | $1.7M | −$1.6M |
| Jan 2023 | $20K | $194K | −$174K |
| Dec 2022 | $2.4M | $22.9M | −$20.5M |
| Nov 2022 | $0 | $519K | −$519K |
| Oct 2022 | $52K | $5.9M | −$5.9M |
| Sep 2022 | $0 | $133K | −$133K |
GEDTX Assets Under Management
Net assets of GMO Emerging Markets Select Equity Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2023-08-31 | $67.20M |
| 2023-05-31 | $67.57M |
| 2023-02-28 | $126.19M |
| 2022-11-30 | $150.53M |
| 2022-08-31 | $158.94M |
| 2022-05-31 | $687.04M |
| 2022-02-28 | $761.47M |
| 2021-11-30 | $771.16M |
| 2021-08-31 | $931.62M |
| 2021-05-31 | $1.03B |
| 2021-02-28 | $1.04B |
| 2020-11-30 | $1.01B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.